[27PO8-am1] Social pharmacy-2/Pharmacoepidemiology

[27PO8-am1-20] The safety of pranlukast and montelukast during the first trimester of pregnancy: a prospective, two-centered cohort study in Japan

○Shiro Hatakeyama¹, Mikako Goto², Ayaka Yamamoto¹, Jiro Ogura¹, Norikazu Watanabe³, Seiji Tsutsumi⁴, Naho Yakuwa², Ritsuko Yamane⁵, Satoru Nagase³, Kunihiko Takahashi⁶, Rika Kosaki⁷, Atsuko Murashima⁸, Hiroaki Yamaguchi¹ (1. Department of Pharmacy, Yamagata University Hospital, 2. The Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, 3. Department of Obstetrics and Gynecology, Yamagata University Faculty of Medicine, 4. Department of Obstetrics and Gynecology, Yamagata Prefecture Central Hospital, 5. Department of pharmacy, Toranomon Hospital, 6. M&D Data Science Center, Tokyo Medical and Dental University, 7. Division of Medical Genetics, National Center for Child Health and Development, 8. Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development)